Prelude Therapeutics PRLD Price Prediction

The determination to procure Prelude Therapeutics is entirely contingent on your individualistic risk tolerance. As you may discern, Prelude Therapeutics's value has experienced an escalation of 1.06% during the preceding 24 hours, and Prelude Therapeutics has incurred a decline of -0.52% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Prelude Therapeutics will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Prelude Therapeutics may potentially surge to $4.22 by the end of this year. Looking at Prelude Therapeutics's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $4.00. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Prelude Therapeutics forecast, the price of Prelude Therapeutics will increase by 0.93% over the next week and reach $3.85 by October 13, 2026.

Based on the our new experimental Prelude Therapeutics forecast, the price of Prelude Therapeutics will increase by 7.34% over the next month and reach $4.09 by November 5, 2026.

As per our most recent prediction on Prelude Therapeutics's value in 2026, PRLD is anticipated to fluctuate within the range of $3.78 and $4.22. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Prelude Therapeutics price forecast fails to consider sudden and extreme price fluctuations.

Prelude Therapeutics's future appears to be on an upward trend, with an maximum price of $4.00 projected after a period of five years. Based on the Prelude Therapeutics forecast for 2031, Prelude Therapeutics's value may potentially reach its highest peak of approximately $4.00, while its lowest peak is anticipated to be around $3.57.

Based on the our new experimental Prelude Therapeutics price prediction simulation, PRLD’s value in 2026 expected to grow by 10.77% to $4.22 if the best happened. The price will be between $4.22 and $3.78 during 2026.

According to our latest experimental simulation for Prelude Therapeutics price prediction, PRLD’s value could rise by 16.72% to $4.44 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $4.44 and $3.40 throughout the year.

Our new experimental Prelude Therapeutics price prediction model suggests that PRLD’s value in 2028 could down by -4.58%, reaching $3.63 in the best-case scenario. The price is expected to range between $3.63 and $2.64 during the year.

Based on our experimental forecast model, Prelude Therapeutics's value may experience a -15.28% fall in 2029, potentially reaching $3.22 under optimal conditions. The predicted price range for 2029 lies between $3.22 and $2.67.

Using our new experimental simulation for Prelude Therapeutics price predictions, PRLD’s value in 2030 is expected to rise by 1.53% , reaching $3.86 in the best scenario. The price is forecasted to range between $3.86 and $2.83 over the course of 2030.

Our experimental simulation indicates that Prelude Therapeutics’s price could grow by 5.22% in 2031, potentially hitting $4.00 under ideal conditions. The price will likely fluctuate between $4.00 and $3.57 during the year.

Based on the findings from our latest experimental Prelude Therapeutics price prediction, PRLD could see a 27.72% rise in value, reaching $4.86 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $4.86 and $3.89 throughout the year.

According to our experimental Prelude Therapeutics price prediction, PRLD’s value is anticipated to rise by 65.96% in 2033, with the highest potential price being $6.32. Throughout the year, PRLD’s price could range from $6.32 and $4.87.

The results from our new Prelude Therapeutics price prediction simulation suggest that PRLD may rise by 93.43% in 2034, potentially reaching $7.36 under the best circumstances. The predicted price range for the year is between $7.36 and $6.11.

Based on our experimental forecast for Prelude Therapeutics’s price, PRLD could grow by 145.6% , with the value potentially hitting $9.35 in 2035. The expected price range for the year lies between $9.35 and $6.91.

Our recent Prelude Therapeutics price prediction simulation suggests that PRLD’s value might rise by 245.28% in 2036, possibly reaching $13.15 if conditions are optimal. The expected price range for 2036 is between $13.15 and $8.87.

According to the experimental simulation, Prelude Therapeutics’s value could rise by 349.22% in 2037, with a high of $17.11 under favorable conditions. The price is expected to fall between $17.11 and $12.89 over the course of the year.